Drugs / Multivalent Pneumococcal Vaccine - Formulation 4
Multivalent Pneumococcal Vaccine - Formulation 4
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06182124 | Dec 2023 → May 2026 | pneumococcal infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Multivalent Pneumococcal Vaccine - Formulation 4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06182124 ↗ |
| Modality | Vaccine | “pneumococcal vaccine” NCT06182124 ↗ |
| Route | Intramuscular | “single shot into the upper arm muscle” NCT06182124 ↗ |